Member Info for bamb

Https://www.youtube.com/watch?v=-SrvVD-EXNk

33 minutes in

Nm

Down to 10p IMO...this is only going one way folks

Lol

Toffers, you don't know want you're on about...so where is this test? When is it coming to the market? Well...When I last looked it hadn't got anywhere...enlighten me

No chance thick soup, should have shorted this one

Should see some huge buys later on

Seriously? 'manufacture, package, and also pass meticulous safety standards in the process.'

what are you on about?

Getting a lot of mentions in quality press, which will only attract new buyers...This from ii

...but the stock with real momentum continues to be AIM-listed Oxford BioDynamics following the launch of its EpiSwitch prostate screening test in the US and UK.

In a further boost for shareholders today, the company said the test had been issued with a code that from the start of 2024 should make it easier for Americans to claim for reimbursement under their insurance.

Shares today topped 50p, which compares with 10p prior to last week’s earlier-than-expected disclosure that the EpiSwitch test (PSE) had received validation. The success has been shared by plenty of ii customers after Oxford BioDynamics featured among our most traded stocks last week.

The PSE test is designed to run alongside a standard PSA blood test, predicting with 94% accuracy the presence or absence of prostate cancer. Those with a PSE result of low likelihood of cancer can be placed on active surveillance and retested later without being referred for an invasive and often destructive biopsy.

The test is the culmination of nearly a decade’s collaboration with Imperial College London, University of East Anglia, Imperial College NHS Trust and the UK's leading prostate cancer experts.

1p

OBD don't hang around when they have something very marketable

Funny that Sicker, coz I can sell 100K no probs...

Some huge trades to pop up later

Https://www.voxmarkets.co.uk/articles/oxford-biodynamics-secures-reimbursement-code-for-breakthrough-prostate-screening-test-adc7d3e/?utm_content=266548882&utm_medium=social&utm_source=twitter&hss_channel=tw-1439109236

View from Vox

A key milestone for Oxford BioDynamics, with the rapid issuance of the CPT code reflecting the acknowledgment by payor groups that the PSE test is not only important for patients but also for cost savings in the medical industry.

Early and accurate detection of prostate cancer can lead to more effective treatment and potentially reduce healthcare costs associated with late-stage cancer treatment. In addition, PSE can reduce referrals for unnecessary prostate biopsies, again contributing to time and cost savings.

Currently, from a standard PSA test alone, only 32 of every 100 positive results are subsequently diagnosed with cancer. In contrast, when this test is done in combination with Oxford BioDynamics’ EpiSwitch PSE test, 93 of every 100 positive results are diagnosed with cancer.

Earl...how much are prostate biopsies?

'Who will pay £750 per test?'

Earl, Are you kidding, right?

Do you even understand the implications of the PSE test for the health service?

EarlofAim

Posted in: OBD

Posts: 9,446

Price: 38.00

No Opinion

RE: PCR like tests cost c£1027 Sep 2023 10:56

Sold because to my calculations OBD can't achieve £100m revenue in any year

mark my words......

these tests are for only men with prostate cancer symptoms, not a random vaccination!!!

stay cautious.....

there is a bigger gain in oil company getting licensed in Iraq worth billions.

£30? wtf are you on earl? missed the boat did you?

These guys sound so bitter they missed out

Https://www.youtube.com/watch?v=ueNkWajAW04